Department of Orthopedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu-city, Mie, 514-8507, Japan.
Department of Musculoskeletal Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan.
J Orthop Sci. 2022 Mar;27(2):463-467. doi: 10.1016/j.jos.2020.12.022. Epub 2021 Feb 4.
This study aimed to elucidate the clinical outcomes of patients with small (≤5 cm) high-grade soft tissue sarcoma, who underwent unplanned excision with positive surgical margin, using data from the Bone and Soft Tissue Tumor registry in Japan.
We examined 174 patients (101 males and 73 females; mean age, 59 years) with primary non-metastatic soft tissue sarcoma. The tumor size was ≤5 cm, and tumor histological grade was high in all patients. The mean follow-up duration was 50 months.
Unplanned excision with R1 and R2 margins was reported in 115 (66%) and 59 patients (34%), respectively. After unplanned excision, immediate additional excision was performed in 154 patients, whereas no additional excision was performed in the remaining 20. Of the 154 patients who underwent additional excision, wide surgical margin resection was achieved in 140 patients, while marginal and intralesional resections were achieved in 10 and 3 patients, respectively. Additionally, 93 patients (60%) underwent reconstruction after additional excision. During the last follow-up, 8 patients died of the disease, 22 developed distant metastasis, and 14 reported local recurrence. The 5-year disease-specific survival rate and 5-year metastasis-free survival rate was 93.5% and 85%, respectively. Tumor depth and additional excision after unplanned excision showed statistical significance in the multivariate analysis. The 5-year metastasis-free survival rate was 89.1% in patients with additional excision and 39.2% in those without. Univariate analysis showed an association between additional excision and local control. The 5-year local recurrence-free survival was significantly worse in patients without additional excision after unplanned excision (52.6%) than in those with additional excision (92.8%).
If unplanned excision is performed in patients with small high-grade soft tissue sarcoma, additional excision is recommended for preventing metastasis, along with necessary preparations for reconstruction.
本研究旨在利用日本骨与软组织肿瘤注册中心的数据,阐明行计划性切缘外切除且切缘阳性的小(≤5cm)高级别软组织肉瘤患者的临床结局。
我们检查了 174 名患有原发性非转移性软组织肉瘤的患者(101 名男性和 73 名女性;平均年龄 59 岁)。所有患者的肿瘤大小均≤5cm,且肿瘤组织学分级均为高级。平均随访时间为 50 个月。
115 例(66%)和 59 例(34%)患者行计划性切缘外切除且切缘分别为 R1 和 R2。行计划性切缘外切除后,154 例患者立即行额外切除术,而其余 20 例患者未行额外切除术。在 154 例行额外切除术的患者中,140 例患者行广泛外科切缘切除术,10 例和 3 例患者分别行边缘切除术和肿瘤内切除术。此外,93 例(60%)患者在额外切除术后行重建。末次随访时,8 例患者死于该病,22 例患者发生远处转移,14 例患者报告局部复发。5 年疾病特异性生存率和 5 年无转移生存率分别为 93.5%和 85%。肿瘤深度和计划性切缘外切除后的额外切除术在多因素分析中具有统计学意义。行额外切除术患者的 5 年无转移生存率为 89.1%,未行额外切除术患者为 39.2%。单因素分析显示,额外切除术与局部控制有关。计划性切缘外切除且未行额外切除术患者的 5 年局部无复发生存率(52.6%)显著低于行额外切除术患者(92.8%)。
如果对小高级别软组织肉瘤患者行计划性切缘外切除术,建议行额外切除术以预防转移,并为重建做好必要准备。